| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |